Parallax Volatility Advisers, L.P. Corcept Therapeutics Inc Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $670,732 - $820,530	-33,587 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$23.49 - $30.56 $788,958 - $1.03 Million	33,587 New	33,587 $799,000
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $699,144 - $1.06 Million	-61,926 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $312,308 - $398,339	25,453 Added 69.79%	61,926 $868,000
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $345,978 - $445,249	22,613 Added 163.15%	36,473 $573,000
Q4 2017 Feb 14, 2018	BUY	$15.77 - $20.72 $218,572 - $287,179	13,860	13,860 $250,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.55B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.